{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T20:29:04Z","timestamp":1763497744309,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.vaccine.2019.06.029","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T19:43:53Z","timestamp":1561751033000},"page":"6962-6969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Defining the multiplicity and time of infection for the production of Zaire Ebola virus-like particles in the insect cell-baculovirus expression system"],"prefix":"10.1016","volume":"37","author":[{"given":"Ana Ruth","family":"Pastor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"D\u00edaz-Salinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio T.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-8102","authenticated-orcid":false,"given":"Laura A.","family":"Palomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.06.029_b0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1410863","article-title":"Chimpanzee adenovirus vector Ebola vaccine","volume":"376","author":"Ledgerwood","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.06.029_b0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"New Eng J Med"},{"key":"10.1016\/j.vaccine.2019.06.029_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bej.2009.02.006","article-title":"Ram\u00edrez OT Challenges for the production of virus-like particles in insect cells: the case of rotavirus-like particles","volume":"45","author":"Palomares","year":"2009","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.vaccine.2019.06.029_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/erv.12.153","article-title":"Insect cells as a production platform of complex virus-like particles","volume":"12","author":"Fernandes","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.06.029_b0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/femsre\/fuv031","article-title":"Ebolavirus comparative genomics","volume":"39","author":"Jun","year":"2015","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2019.06.029_b0030","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1128\/JVI.75.11.5205-5214.2001","article-title":"Ebola virus VP40-induced particle formation and association with the lipid bilayer","volume":"75","author":"Jasenosky","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0035","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/JVI.76.10.4855-4865.2002","article-title":"Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP","volume":"76","author":"Noda","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0040","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1128\/JVI.79.4.2413-2419.2005","article-title":"Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-422X-3-31","article-title":"Effect of Ebola virus glycoproteins GP, NP and VP35 on VP40 VLP morphology","volume":"3","author":"Johnson","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2019.06.029_b0050","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1128\/JVI.78.14.7344-7351.2004","article-title":"Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles","author":"Licata","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0055","series-title":"Cell Engineering. Vol. 9 Animal Cell Culture","first-page":"501","article-title":"An overview of cell culture engineering for the insect cell-baculovirus expression vector system (BEVS)","author":"Palomares","year":"2015"},{"key":"10.1016\/j.vaccine.2019.06.029_b0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2008.09.020","article-title":"Protection against lethal challenge by Ebola virus-like particles produced in insect cells","volume":"383","author":"Sun","year":"2009","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0065","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1086\/520612","article-title":"Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.06.029_b0070","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2006.03.021","article-title":"Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies","volume":"35","author":"Ye","year":"2006","journal-title":"Virol"},{"key":"10.1016\/j.vaccine.2019.06.029_b0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/bit.21069","article-title":"Kamen AA Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios","volume":"95","author":"Aucoin","year":"2006","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.029_b0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/bit.10243","article-title":"Strategies for manipulating the relative concentration of recombinant rotavirus structural proteins produced by insect cells","volume":"78","author":"Palomares","year":"2002","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.029_b0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1097-0290(19960120)49:2<130::AID-BIT2>3.0.CO;2-R","article-title":"Production of parvovirus B19 vaccine in insect cells coinfected with double baculoviruses","volume":"49","author":"Tsao","year":"1996","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2019.06.029_b0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2144\/03342bm05","article-title":"Titration of non-occluded baculovirus using a cell viability assay","volume":"34","author":"Mena","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2019.06.029_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.09.001","article-title":"Filovirus proteins for antiviral drug discovery: a structure\/function of analysis of surface glycoproteins and virus entry","volume":"135","author":"Martin","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2019.06.029_b0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1472-6750-7-39","article-title":"Population kinetics during simultaneous infection of insect cells with two different recombinant baculoviruses for the production of rotavirus-like particles","volume":"7","author":"Mena","year":"2007","journal-title":"BMC Biotech"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19307911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:39Z","timestamp":1759401339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19307911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":20,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0264410X19307911"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the multiplicity and time of infection for the production of Zaire Ebola virus-like particles in the insect cell-baculovirus expression system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}